跳至主要内容
临床试验/NCT02018562
NCT02018562已完成不适用

Prospective Evaluation of a Tracheostomy Tube That Enables Communication in Ventilator Dependent Patients - A Pilot Study

Johns Hopkins University2 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2015年2月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
50
试验地点
2
主要终点
Change in Quality of Life

研究概览

简要总结

Verbal communication is vital to critically ill mechanically ventilated patient's quality of life (Hess, 2005). Patients who have a tracheostomy tube may be able to communicate using a speaking valve, however, some patients may not be able to tolerate cuff deflation for use of speaking valve. There are talking tracheostomy tubes that do not require cuff deflation to facilitate speech in this population. Unfortunately, not all candidates are offered these options due to lack of awareness. Recently, at our institution, there has been an increase in the use of these tubes to facilitate speech. One of the talking tracheotomy tubes that has proven to be effective is the Portex Blueline Ultra Suctionaid (BLUSA).

In 2010, we conducted a retrospective review of 4 cases and found that BLUSA tracheostomy helped facilitate communication in this unique population (IRB #: NA_00041547). We would now like to formally conduct a prospective pilot study to evaluate the feasibility of measuring outcomes of patients with a BLUSA using a pretest-posttest research design.

Communication empowers patients and allows healthcare staff to obtain a more accurate assessment of patients' condition and tailor care accordingly. Identifying the predictors of speech intelligibility and the impact of BLUSA on quality of life will promote communication between patients and healthcare providers.

Study Hypothesis: Determine the impact of a talking tracheostomy tube on quality of life in patients requiring prolonged mechanical ventilation in the hospital.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

盲法说明

Unable to mask because patients and care providers were able to visualize the type of tracheostomy tub that was used.

入排标准

年龄范围
18 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Mechanically ventilated via tracheostomy
  • Awake, alert, and attempting to communicate
  • Able to understand English

排除标准

  • Fresh tracheostomy within 48 hours
  • Laryngectomy

研究组 & 干预措施

Intervention

Experimental
  1. The talking tracheostomy trial involves placement of a talking tracheostomy tube (Portex Blueline Ultra Suctionaid Tracheostomy Tube) by respiratory therapist after obtaining an order from an authorized prescriber (Physician or Nurse Practitioner). The Speech-Language Pathologist (SLP) sets up the tracheostomy tube for speech and then determines the optimal air flow required for voicing. This amount of air flow is communicated to the ICU staff for further use.
  2. We will ensure that the SLP meets with the patient for a minimum of 3 sessions within a week to optimize the use of a talking tracheostomy tube.

i. SLP will also assess the duration of successful speech during each session

ii. Sentence intelligibility will also be assessed during the 3rd session. This session will be audio-taped and reviewed by a second rater for sentence intelligibility.

iii. SLP will determine the level of independence with talking tracheostomy during the 3rd session.

干预措施: Portex Blueline Ultra Suctionaid Tracheostomy Tube (Device)

Control

No Intervention

This group will also receive talking tracheostomy tube trial as standard of care but a week later after the pre and post assessments have been completed

结局指标

主要结局

Change in Quality of Life

时间窗: Baseline; 2 weeks post BLUSA

Quality of Life in Mechanically Ventilated Patients Questionnaire (QOL-MV) was used to measure quality of life. It is a 12-item scale with each items 0 - 10 and total score ranges from 0 - 120. Lower scores refers to lower quality of life and Higher scores refer to higher level quality of life. To be assessed at baseline and 2 weeks post Portex Blueline Ultra Suctionaid (BLUSA).

次要结局

  • Patient Satisfaction With a Talking Tracheostomy Tube(2 weeks)
  • Level of Independence With Talking Tracheostomy Tube(2 weeks)
  • Overall Hospital Length of Stay(Time of discharge from the hospital (Approximately 6-8 months))
  • Intensive Care Unit (ICU) Length of Stay(Time of discharge from the ICU (Approximately 6-8 months))
  • Speech Intelligibility(2 weeks)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Evaluation of a Tracheostomy Tube That Enables... | 临床试验